News BizJournals – Children’s National Hospital spinout ReveraGen BioPharma gearing up for muscular dystrophy drug launch By Sara Gilgore - Staff Reporter November 14, 2023, 03:14pm EST Updated 18 hours ago Rockville’s ReveraGen BioPharma Inc., a 15-year-old Children’s…AndyNovember 15, 2023
News Children’s National Hospital selected as member of ARPA-H Investor Catalyst Hub spoke network The hospital will advocate for the unique needs of children as part of nationwide network working to accelerate transformative health…AndyNovember 14, 2023
News Selecta Biosciences Announces Merger with Cartesian Therapeutics WATERTOWN, Mass. and GAITHERSBURG, Md., Nov. 13, 2023 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ: SELB) (the Company) today announced that…AndyNovember 13, 2023
News BioTalk – Driving Cancer Research Innovation: A Conversation with Michael Weingarten, Director, SBIR Development Center at the National Cancer Institute (NCI) What are the latest advancements in cancer research and innovation? Join us in this episode of BioTalk with Rich Bendis…AndyNovember 13, 2023
News BioHealth Innovation, Inc. Welcomes Dr. Eric S. Edwards of Phlow Corporation to the Board of Directors and Appoints Donna J. Edmonds of BRAINBox Solutions, Inc. as Vice Chair ROCKVILLE, MARYLAND, November 13, 2023 – BioHealth Innovation, Inc. (BHI), a leading organization dedicated to supporting and advancing the BioHealth…AndyNovember 13, 2023
News The NHLBI is accepting applications for the I-Corps at NIH™ Program The NHLBI is accepting applications for the I-Corps at NIH™ Program, which provides funding, mentoring, and networking opportunities to current Phase I SBIR/STTR awardees and Fast-Track awardees in…AndyNovember 9, 2023
News VLP Therapeutics group announces 3rd closing of funding to develop cancer, infectious disease vaccines; establish investigational vaccine manufacturing facility US-based biotech company VLP Therapeutics, Inc. (VLPT) and its Tokyo-based group company VLP Therapeutics Japan, Inc. (VLPT Japan) together announced…AndyNovember 8, 2023
News Emergent BioSolutions Submits Supplemental Biologics License Application Seeking U.S. FDA Approval of ACAM2000®, (Smallpox (Vaccinia) Vaccine, Live) for Immunization Against Mpox GAITHERSBURG, Md., November 7, 2023 – Emergent (NYSE: EBS) has recently submitted a supplemental Biologics License Application (sBLA) to the…AndyNovember 8, 2023
News Irazú Oncology and University of Maryland, Baltimore Mark Anniversary of Exclusive License for Development of Colorectal Cancer Vaccine BALTIMORE, MD, November 7, 2023 –Irazú Oncology, LLC, a biotechnology research company working to develop the next generation of cancer…AndyNovember 7, 2023
News Endpoints News Exclusive: With backing of Ravens owner, Blackbird launches with $100M to boost Baltimore’s biotech scene A life sciences accelerator called Blackbird Laboratories has $100 million to spend to turn Baltimore into a biotech hub.A life…AndyNovember 7, 2023